Summaries for patients. Management of nonvariceal upper gastrointestinal bleeding.
D000208:Acute Disease; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001803:Blood Transfusion; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control / Q000628:therapy*; D016558:Hemostasis, Endoscopic; D006489:Hemostatic Techniques; D006801:Humans; D011379:Prognosis; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment; D055502:Secondary Prevention; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D052246:Cyclooxygenase 2 Inhibitors; D054328:Proton Pump Inhibitors; D014662:Vasoconstrictor Agents; D001241:Aspirin; D004837:Epinephrine